InnovAge Holding Corp.
INNV Nasdaq· Services-Health Services
Last close · Oct 27, 2026
$9.12
KIRA · Stoqly’s AI analyst, in plain words
- InnovAge Holding Corp. had $990M of revenue in fiscal 2026, up 15.9% on the year before. Over five years, revenue changed +9.2% a year on average.
- Its operating margin was 0.3%, up 3.8 pts: of every 100 in sales, about 0 is left after running the business.
- InnovAge Holding Corp. lost $2.5M in fiscal 2026.
- Free cash flow was $50.4M in fiscal 2026, 5.1% of revenue.
- InnovAge Holding Corp. has $78.0M more cash than debt.
Market cap
$1.2B
P/E
—
Revenue
$990M
Net income
−$2.5M
Free cash flow
$50.4M
Operating margin
0.3%
InnovAge Holding Corp. in 30 seconds · fiscal 2026
Are sales growing?
+15.9%
Yes. Sales grew 15.9% last year.
Does it make a profit?
−0.3%
No. It lost money last year.
Does profit turn into cash?
5.1%
Partly. 5.1% of sales ends up as free cash.
Is debt under control?
Net cash
Yes. It has more cash than debt.
How healthy are the accounts?
6 / 9
Mixed. It passes 6 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What InnovAge Holding Corp. does
No business description yet.
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 10-K · Sep 9, 2026
- Legal name
- InnovAge Holding Corp.
- CIK
- 0001834376
InnovAge Holding Corp. · INNV
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $699M | $688M | $764M | $854M | $990M |
| Revenue growth | 9.5% | −1.5% | 11.0% | 11.8% | 15.9% |
| Gross margin | 19.4% | 14.7% | 17.3% | 18.0% | 23.0% |
| Operating margin | −0.6% | −7.2% | −3.0% | −3.5% | 0.3% |
| Net income | −$6.5M | −$40.7M | −$21.3M | −$30.3M | −$2.5M |
| Net margin | −0.9% | −5.9% | −2.8% | −3.6% | −0.3% |
| Diluted EPS | −$0.05 | −$0.30 | −$0.16 | −$0.22 | −$0.02 |
| Cash | |||||
| Cash from operations | $27.3M | $20.2M | −$36.9M | $32.9M | $64.7M |
| Capital expenditure | $38.2M | $23.4M | $7.9M | $6.3M | $14.3M |
| Free cash flow | −$10.9M | −$3.1M | −$44.8M | $26.6M | $50.4M |
| FCF margin | −1.6% | −0.5% | −5.9% | 3.1% | 5.1% |
| Share count change | 9.6% | 0.1% | 0.2% | −0.4% | 0.2% |
| Debt and strength | |||||
| Cash and short-term investments | $184M | $173M | $103M | $106M | $141M |
| Debt incl. finance leases | $73.6M | $87.6M | $83.3M | $72.8M | $63.3M |
| Shareholders' equity | $332M | $296M | $269M | $235M | $236M |
| Net debt / EBITDA | −11.6x | — | — | — | −3.3x |
| Current ratio | 2.3x | 1.4x | 1.2x | 1.1x | 1.1x |
| Interest coverage | −1.7x | — | — | — | — |
| Returns and quality | |||||
| Return on capital | −1.6% | −20.3% | −7.9% | −12.4% | 1.2% |
| Return on equity | −2.0% | −12.9% | −7.5% | −12.0% | −1.1% |
| Return on tangible equity | −3.2% | −24.4% | −17.1% | −34.0% | −2.8% |
| Piotroski F-score | 5 | 3 | 4 | 6 | 6 |
| Altman Z'' | 3.3 | 1.2 | 0.9 | 0.1 | 0.4 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$107M
4 insiders
Of sales under plans
0%
$0.2M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
InnovAge Holding Corp. · INNV
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $9.12 a share, the company is worth $1.2B.
Source: SEC EDGAR XBRL filings (CIK 0001834376). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.